Frequent Allelic Loss of Dkk-1 Locus (10q11.2) is Related with Low Distant Metastasis and Better Prognosis in Head and Neck Squamous Cell Carcinomas

REFERENCES

• Platz, H.; Fries, R.; Hudec, M. Retrospective DOSAK study on carcinomas of the oral cavity: results and consequences. J Maxillofac Surg 1985, 13, 147–153.
   PubMed Web of Science ®Google Scholar
• Kearsley, J.H.; Thomas, S. Prognostic markers in cancers of the head and neck region. Anticancer Drug 1993, 4, 419–429.
   Google Scholar
• Roland, N.J.; Caslin, A.W.; Nash, J.; Stell, P.M. Value of grading squamous cell carcinoma of the head and neck. Head Neck 1992, 14, 224–229.
   PubMed Web of Science ®Google Scholar
• Báez, A. Genetic and environmental factors in head and neck cancer genesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008, 26, 174–200.
   PubMed Web of Science ®Google Scholar
• Brennan, J.A.; Boyle, J.O.; Koch, W.M.; Goodman, S.N.; Hruban, R.H.; Eby, Y.J.; Couch, M.J.; Forastiere, A.A.; Sidransky, D. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995, 332, 712–717.
   PubMed Web of Science ®Google Scholar
• Shimizu, S.; Seki, N.; Sugimoto, T.; Horiguchi, S.; Tanzawa, H.; Hanazawa, T.; Okamoto, Y. Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling. Oncol Rep 2007, 18, 1489–1497.
   PubMed Web of Science ®Google Scholar
• Willmore-Payne, C.; Holden, J.A.; Layfield, L.J. Detection of EGFR- and HER2- activating mutation in squamous cell carcinoma involving the head and neck. Mod Pathol 2006, 19, 634–640.
   PubMed Web of Science ®Google Scholar
• Reed, A.L.; Califano, J.; Cairns, P.; Westra, W.H.; Jones, R.M.; Koch, W.; Ahrendt, S.; Eby, Y.; Sewell, D.; Nawroz, H.; Bartek, J.; Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996, 56, 3630–3633.
   PubMed Web of Science ®Google Scholar
• Gunduz, M.; Ouchida, M.; Fukushima, K.; Hanafusa, H.; Etani, T.; Nishioka, S.; Nishizaki, K.; Shimizu, K. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 2000, 60, 3143–3146.
   PubMed Web of Science ®Google Scholar
• Gunduz, M.; Ouchida, M.; Fukushima, K.; Ito, S.; Jitsumori, Y.; Nakashima, T.; Nagai, N.; Nishizaki, K.; Shimizu, K Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 2002, 21, 4462–4470.
   PubMed Web of Science ®Google Scholar
• Gunduz, M.; Nagatsuka, H.; Demircan, K.; Gunduz, E.; Cengiz, B.; Ouchida, M.; Tsujigiwa, H.; Yamachika, E.; Fukushima, K.; Beder, L.B.; Hirohata, S.; Ninomiya, Y.; Nishizaki, K.; Shimizu, K.; Nagai, N. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 2005, 356, 109–117.
   PubMed Web of Science ®Google Scholar
• Beder, L.B.; Gunduz, M.; Ouchida, M.; Fukushima, K.; Gunduz, E.; Ito, S.; Sakai, A.; Nagai, N.; Nishizaki, K.; Shimizu, K. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 2003, 83, 99–105.
   PubMed Web of Science ®Google Scholar
• Sato, H.; Suzuki, H.; Toyota, M.; Nojima, M.; Maruyama, R.; Sasaki, S.; Takagi, H.; Sogabe, Y.; Sasaki, Y.; Idogawa, M.; Sonoda, T.; Mori, M.; Imai, K.; Tokino, T.; Shinomura, Y. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 2007, 28, 2459–2466.
   PubMed Web of Science ®Google Scholar
• Moon, R.T.; Kohn, A.D.; De Ferrari, G.V.; Kaykas, A. WNT and beta-catenin signaling: diseases and therapies. Nat Rev Genet 2004, 5, 691–701.
   PubMed Web of Science ®Google Scholar
• Veeman, M.T.; Axelrod, J.D.; Moon, R.T. A second canon: functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003, 5, 367–377.
   PubMed Web of Science ®Google Scholar
• Kawano, Y.; Kypta, R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116, 2627–2634.
   PubMed Web of Science ®Google Scholar
• Licchesi, J.D.; Westra, W.H.; Hooker, C.M.; Machida, E.O.; Baylin, S.B.; Herman, J.G. Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Carcinogenesis 2008, 29, 895–904.
   PubMed Web of Science ®Google Scholar
• Urakami, S.; Shiina, H.; Enokida, H.; Hirata, H.; Kawamoto, K.; Kawakami, T.; Kikuno, N.; Tanaka, Y.; Majid, S.; Nakagawa, M.; Igawa, M.; Dahiya, R. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res 2006, 12, 6989–6997.
   PubMed Web of Science ®Google Scholar
• Urakami, S.; Shiina, H.; Enokida, H.; Kawakami, T.; Kawamoto, K.; Hirata, H.; Tanaka, Y.; Kikuno, N.; Nakagawa, M.; Igawa, M.; Dahiya, R. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 2006, 12, 2109–2116. .
   PubMed Web of Science ®Google Scholar
• Kuphal, S.; Lodermeyer, S.; Bataille, F.; Schuierer, M.; Hoang, B.H.; Bosserhoff, A.K. Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 2006, 25, 5027–5036.
   PubMed Web of Science ®Google Scholar
• Lodygin, D.; Epanchintsev, A.; Menssen, A.; Diebold, J.; Hermeking, H. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 2005, 65, 4218–4227.
   PubMed Web of Science ®Google Scholar
• Ha, P.K.; Califano, J.A. Promoter methylation and inactivation of tumor-suppressor genes in oral squamous cell carcinoma. Lancet Oncol 2006, 7, 77–82.
   PubMed Web of Science ®Google Scholar
• Niehrs, C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25, 7469–7481.
   PubMed Web of Science ®Google Scholar
• Niida, A.; Hiroko, T.; Kasai, M.; Furukawa, Y.; Nakamura, Y.; Suzuki, Y.; Sugano, S.; Akiyama, T. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 2004, 23, 8520–8526.
   PubMed Web of Science ®Google Scholar
• González-Sancho, J.M.; Aguilera, O.; García, J.M.; Pendás-Franco, N.; Peña, C.; Cal, S.; García de Herreros, A.; Bonilla, F.; Muñoz, A. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 2005, 24, 1098–1103.
   PubMed Web of Science ®Google Scholar
• Mao, B.; Niehrs, C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 2003, 302, 179–183.
   PubMed Web of Science ®Google Scholar
• Katase, N.; Gunduz, M.; Beder, L.B.; Gunduz, E.; Lefeuvre, M.; Hatipoglu, O.F.; Borkosky, S.S.; Tamamura, R.; Tominaga, S.; Yamanaka, N.; Shimizu, K.; Nagai, N.; Nagatsuka, H. Deletion at Dickkopf (Dkk)-3 Locus (11p15.2) is related with lower lymph node metastasis and better prognosis in head and neck squamous cell carcinomas. Oncology Res 2008, 17, 273–282.
   PubMed Web of Science ®Google Scholar
• Pendás-Franco, N.; García, J.M.; Peña, C.; Valle, N.; Pálmer, H.G.; Heinäniemi, M.; Carlberg, C.; Jiménez, B.; Bonilla, F.; Muñoz, A.; González-Sancho, J.M. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1 alpha, 25-dihydroxyvitamin D3. Oncogene 2008, 27, 4467–4477.
   PubMed Web of Science ®Google Scholar
• Aguilera, O.; Fraga, M.F.; Ballestar, E.; Paz, M.F.; Herranz, M.; Espada, J.; García, J.M.; Muñoz, A.; Esteller, M.; González-Sancho, J.M. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 2006, 25, 4116–4121.
   PubMed Web of Science ®Google Scholar
• Lee, J.; Yoon, Y.S.; Chung, J.H. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines. Gynecol Oncol 2008, 109, 270–274.
   PubMed Web of Science ®Google Scholar
• Qin, X.; Zhang, H.; Zhou, X.; Wang, C.; Zhang, H.; Zhang, X.; Ye, L. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Transl Res 2007, 150, 281–294.
   PubMed Web of Science ®Google Scholar
• Mikheev, A.M.; Mikheeva, S.A.; Rostomily, R.; Zarbl, H. Dickkopf-1 activates cell death in MDA-MB435 melanoma cells. Biochem Biophys Res Commun 2007, 352, 675–680.
   PubMed Web of Science ®Google Scholar